Literature DB >> 11168424

Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3).

B Arza1, M De Maeyer, J Félez, D Collen, H R Lijnen.   

Abstract

To test the hypothesis that Glu202, adjacent to the His201 residue that participates in the coordination of Zn(2+) in matrix metalloproteinase-3 (MMP-3 or stromelysin-1), plays a role in its enzymatic activity it was substituted with Ala, Lys or Asp by site-specific mutagenesis. Wild-type proMMP-3, proMMP-3(E202A), proMMP-3(E202K) and proMMP-3(E202D) were expressed in Escherichia coli and purified to apparent homogeneity. Whereas 33-kDa wild-type proMMP-3 (consisting of the propeptide and catalytic domains) was quantitatively converted to 24-kDa active MMP-3 by treatment with p-aminophenyl-mercuric acetate (APMA), proMMP-3(E202A) and proMMP-3 (E202K) were fully resistant to APMA and proMMP-3 (E202D) was quantitatively converted into a 14-kDa species. In contrast, treatment with plasmin quantitatively converted the wild-type and the three mutant proMMP-3 moieties into the corresponding 24-kDa MMP-3 moieties. Biospecific interaction analysis revealed comparable affinity for binding to plasminogen of wild-type and mutant proMMP-3 (K(a) of 2.6-6.3 x 10(6) M(-1)) or MMP-3 (K(a) of 33-58 x 10(6) M(-1)) moieties. The affinity for binding to single-chain urokinase-type plasminogen activator (scu-PA) was also similar for wild-type and mutant proMMP-3 (K(a) of 5.0-6.9 x 10(6) M(-1)) or MMP-3 (K(a) of 37-72 x 10(6) M(-1)) moieties. However, MMP-3(E202A) and MMP-3(E202K) did not hydrolyze plasminogen whereas MMP-3(E202D) showed an activity of 20--30% of wild-type MMP-3. All three mutants were inactive towards scu-PA under conditions where this was quantitatively cleaved by wild-type MMP-3. Furthermore, MMP-3(E202A) and MMP-3(E202K) were inactive toward a fluorogenic substrate and MMP-3 (E202D) displayed about 15% of the activity of wild-type MMP-3. Taken together, these data suggest that Glu202 plays a crucial role in the enzymatic activity of MMP-3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168424     DOI: 10.1046/j.1432-1327.2001.01943.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis.

Authors:  Karim Si-Tayeb; Arnaud Monvoisin; Claire Mazzocco; Sébastien Lepreux; Marion Decossas; Gaëlle Cubel; Danièle Taras; Jean-Frédéric Blanc; Derrick R Robinson; Jean Rosenbaum
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

2.  A reinforced merging methodology for mapping unique peptide motifs in members of protein families.

Authors:  Hao-Teng Chang; Tun-Wen Pai; Tan-chi Fan; Bo-Han Su; Pei-Chih Wu; Chuan-Yi Tang; Chun-Tien Chang; Shi-Hwei Liu; Margaret Dah-Tsyr Chang
Journal:  BMC Bioinformatics       Date:  2006-01-25       Impact factor: 3.169

3.  Identification of a thrombin cleavage site and a short form of ADAMTS-18.

Authors:  Jianhui Wang; Wei Zhang; Zanhua Yi; Shiyang Wang; Zongdong Li
Journal:  Biochem Biophys Res Commun       Date:  2012-02-23       Impact factor: 3.575

4.  An integrated computational approach to rationalize the activity of non-zinc-binding MMP-2 inhibitors.

Authors:  Antonella Di Pizio; Mariangela Agamennone; Massimiliano Aschi
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.